BioCorRx Inc. (BICX)

[236T568]

Remember that False and misleading $15.00/share price on the subscription agreement for those 400,000 common shares?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148174473


Well, it turns out that scam company BICX is now admitting that the price was NOT $15.00, but much much lower.

Here BICX booked $1.56 million, or $3.90/share for the subscription agreement in the Balance Sheet as of March 31, 2019

https://www.sec.gov/Archives/edgar/data/1443863/000147793219002713/bicx_10q.htm

"Common stock subscription receivable ( Note 11) (1,560,000)"


and has stated that, during the 2nd quarter, it will ALLOCATE the $6.0 million received between the Subscription Agreement and the Royalty Agreement

"In March 2019, the Company issued an aggregate of 400,000 shares of its common stock under these Subscription and Royalty Agreements and subsequently in April 2019 received the proceeds. At March 31, 2019, the common shares were recorded at fair market value at the date of the agreements as a subscription receivable of $1,560,000 in the Company’s stockholder’s deficit until the subsequent proceeds are allocated between the common stock and royalty agreements. The Company will assess the allocation of the value between the subscription and royalty agreement in the second quarter when all the funds were received."